PregLem SA
Overview
PregLem SA, a private biopharmaceutical company, is dedicated to developing innovative treatments for women's reproductive health conditions. The company focuses on novel therapies targeting conditions such as endometriosis, uterine fibroids, and infertility.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to PregLem SA in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.